APO Research
Talk to an analyst

APO RESEARCH · REPORT

HIV Therapy Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global HIV Therapy Drug Industry Growth and Trends Forecast to 2032

29 December 2025126 pages

Choose your research edition.

Industry ResearchHIV Therapy Drug Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal HIV Therapy Drug Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal HIV Therapy Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HIV Therapy Drug Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal HIV Therapy Drug Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global HIV Therapy Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for HIV Therapy Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for HIV Therapy Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for HIV Therapy Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of HIV Therapy Drug include AbbVie Inc., Affine Formulations Limited, Beacon Pharmaceuticals, Biocon Limited, Boehringer Ingelheim, Bristol-Myers Squibb Company, Cipla, Frontier Biotechnologies and Genentech, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global HIV Therapy Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The HIV Therapy Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global HIV Therapy Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to HIV Therapy Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global HIV Therapy Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

HIV Therapy Drug Market by Company

AbbVie Inc.

Affine Formulations Limited

Beacon Pharmaceuticals

Biocon Limited

Boehringer Ingelheim

Bristol-Myers Squibb Company

Cipla

Frontier Biotechnologies

Genentech, Inc.

Gilead Sciences, Inc

IPCA Laboratories

Janssen Pharmaceuticals, Inc.

Julphar Bangladesh

Merck & Co

MSD

Mylan Pharmaceuticals Inc.

Natco Pharma

Roche Holding AG

Shionogi

Theratechnologies Inc.

ViiV Healthcare

GSK

Pfizer

Johnson & Johnson

Teva Pharmaceuticals

Abbott

HIV Therapy Drug Segment by Type

Hiv Integrated Enzyme Chain Transfer Inhibitor

Multi-Type Combined Drugs

Non-Nucleoside Reverse Transcription Enzyme Inhibitors

Nucleoside Reverse Transcription Enzyme Inhibitors

HIV Therapy Drug Segment by Application

Hospital

Clinic

Pharmacy

HIV Therapy Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HIV Therapy Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HIV Therapy Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HIV Therapy Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of HIV Therapy Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of HIV Therapy Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hiv Integrated Enzyme Chain Transfer Inhibitor Table 2. Major Company of Multi-Type Combined Drugs Table 3. Major Company of Non-Nucleoside Reverse Transcription Enzyme Inhibitors Table 4. Major Company of Nucleoside Reverse Transcription Enzyme Inhibitors Table 5. Global HIV Therapy Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global HIV Therapy Drug Sales by Type (2021-2026) & (K Units) Table 7. Global HIV Therapy Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global HIV Therapy Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global HIV Therapy Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global HIV Therapy Drug Price by Type (2021-2026) & (US$/Unit) Table 11. Global HIV Therapy Drug Sales by Type (2027-2032) & (K Units) Table 12. Global HIV Therapy Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global HIV Therapy Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global HIV Therapy Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global HIV Therapy Drug Price by Type (2027-2032) & (US$/Unit) Table 16. North America HIV Therapy Drug Sales by Type (2021-2026) & (K Units) Table 17. North America HIV Therapy Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe HIV Therapy Drug Sales by Type (2021-2026) & (K Units) Table 19. Europe HIV Therapy Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific HIV Therapy Drug Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific HIV Therapy Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America HIV Therapy Drug Sales by Type (2021-2026) & (K Units) Table 23. Latin America HIV Therapy Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa HIV Therapy Drug Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa HIV Therapy Drug Sales by Type (2021-2026) & (US$ Million) Table 26. HIV Therapy Drug Industry Trends Table 27. HIV Therapy Drug Industry Drivers Table 28. HIV Therapy Drug Industry Opportunities and Challenges Table 29. HIV Therapy Drug Industry Restraints Table 30. Global HIV Therapy Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global HIV Therapy Drug Revenue Market Share by Company (2021-2026) Table 32. Global HIV Therapy Drug Sales by Company (2021-2026) & (K Units) Table 33. Global HIV Therapy Drug Sales Share by Company (2021-2026) Table 34. Global HIV Therapy Drug Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global HIV Therapy Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global HIV Therapy Drug Major Company Production Sites and Headquarters Table 37. Global HIV Therapy Drug Company, Product Type & Application Table 38. Global HIV Therapy Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global HIV Therapy Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global HIV Therapy Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global HIV Therapy Drug Sales by Region (2021-2026) & (K Units) Table 43. Global HIV Therapy Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global HIV Therapy Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global HIV Therapy Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global HIV Therapy Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global HIV Therapy Drug Sales by Region (2027-2032) & (K Units) Table 48. Global HIV Therapy Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global HIV Therapy Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global HIV Therapy Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global HIV Therapy Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global HIV Therapy Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global HIV Therapy Drug Sales by Application (2021-2026) & (K Units) Table 54. Global HIV Therapy Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global HIV Therapy Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global HIV Therapy Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global HIV Therapy Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global HIV Therapy Drug Sales by Application (2027-2032) & (K Units) Table 59. Global HIV Therapy Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global HIV Therapy Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global HIV Therapy Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global HIV Therapy Drug Price by Application (2027-2032) & (US$/Unit) Table 63. North America HIV Therapy Drug Sales by Application (2021-2026) & (K Units) Table 64. North America HIV Therapy Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe HIV Therapy Drug Sales by Application (2021-2026) & (K Units) Table 66. Europe HIV Therapy Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific HIV Therapy Drug Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific HIV Therapy Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America HIV Therapy Drug Sales by Application (2021-2026) & (K Units) Table 70. Latin America HIV Therapy Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa HIV Therapy Drug Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa HIV Therapy Drug Sales by Application (2021-2026) & (US$ Million) Table 73. AbbVie Inc. Company Information Table 74. AbbVie Inc. Business Overview Table 75. AbbVie Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. AbbVie Inc. HIV Therapy Drug Product Portfolio Table 77. AbbVie Inc. Recent Development Table 78. Affine Formulations Limited Company Information Table 79. Affine Formulations Limited Business Overview Table 80. Affine Formulations Limited HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Affine Formulations Limited HIV Therapy Drug Product Portfolio Table 82. Affine Formulations Limited Recent Development Table 83. Beacon Pharmaceuticals Company Information Table 84. Beacon Pharmaceuticals Business Overview Table 85. Beacon Pharmaceuticals HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Beacon Pharmaceuticals HIV Therapy Drug Product Portfolio Table 87. Beacon Pharmaceuticals Recent Development Table 88. Biocon Limited Company Information Table 89. Biocon Limited Business Overview Table 90. Biocon Limited HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Biocon Limited HIV Therapy Drug Product Portfolio Table 92. Biocon Limited Recent Development Table 93. Boehringer Ingelheim Company Information Table 94. Boehringer Ingelheim Business Overview Table 95. Boehringer Ingelheim HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Boehringer Ingelheim HIV Therapy Drug Product Portfolio Table 97. Boehringer Ingelheim Recent Development Table 98. Bristol-Myers Squibb Company Company Information Table 99. Bristol-Myers Squibb Company Business Overview Table 100. Bristol-Myers Squibb Company HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Bristol-Myers Squibb Company HIV Therapy Drug Product Portfolio Table 102. Bristol-Myers Squibb Company Recent Development Table 103. Cipla Company Information Table 104. Cipla Business Overview Table 105. Cipla HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Cipla HIV Therapy Drug Product Portfolio Table 107. Cipla Recent Development Table 108. Frontier Biotechnologies Company Information Table 109. Frontier Biotechnologies Business Overview Table 110. Frontier Biotechnologies HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Frontier Biotechnologies HIV Therapy Drug Product Portfolio Table 112. Frontier Biotechnologies Recent Development Table 113. Genentech, Inc. Company Information Table 114. Genentech, Inc. Business Overview Table 115. Genentech, Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Genentech, Inc. HIV Therapy Drug Product Portfolio Table 117. Genentech, Inc. Recent Development Table 118. Gilead Sciences, Inc Company Information Table 119. Gilead Sciences, Inc Business Overview Table 120. Gilead Sciences, Inc HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Gilead Sciences, Inc HIV Therapy Drug Product Portfolio Table 122. Gilead Sciences, Inc Recent Development Table 123. IPCA Laboratories Company Information Table 124. IPCA Laboratories Business Overview Table 125. IPCA Laboratories HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. IPCA Laboratories HIV Therapy Drug Product Portfolio Table 127. IPCA Laboratories Recent Development Table 128. Janssen Pharmaceuticals, Inc. Company Information Table 129. Janssen Pharmaceuticals, Inc. Business Overview Table 130. Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Janssen Pharmaceuticals, Inc. HIV Therapy Drug Product Portfolio Table 132. Janssen Pharmaceuticals, Inc. Recent Development Table 133. Julphar Bangladesh Company Information Table 134. Julphar Bangladesh Business Overview Table 135. Julphar Bangladesh HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Julphar Bangladesh HIV Therapy Drug Product Portfolio Table 137. Julphar Bangladesh Recent Development Table 138. Merck & Co Company Information Table 139. Merck & Co Business Overview Table 140. Merck & Co HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Merck & Co HIV Therapy Drug Product Portfolio Table 142. Merck & Co Recent Development Table 143. MSD Company Information Table 144. MSD Business Overview Table 145. MSD HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. MSD HIV Therapy Drug Product Portfolio Table 147. MSD Recent Development Table 148. Mylan Pharmaceuticals Inc. Company Information Table 149. Mylan Pharmaceuticals Inc. Business Overview Table 150. Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Mylan Pharmaceuticals Inc. HIV Therapy Drug Product Portfolio Table 152. Mylan Pharmaceuticals Inc. Recent Development Table 153. Natco Pharma Company Information Table 154. Natco Pharma Business Overview Table 155. Natco Pharma HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 156. Natco Pharma HIV Therapy Drug Product Portfolio Table 157. Natco Pharma Recent Development Table 158. Roche Holding AG Company Information Table 159. Roche Holding AG Business Overview Table 160. Roche Holding AG HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 161. Roche Holding AG HIV Therapy Drug Product Portfolio Table 162. Roche Holding AG Recent Development Table 163. Shionogi Company Information Table 164. Shionogi Business Overview Table 165. Shionogi HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 166. Shionogi HIV Therapy Drug Product Portfolio Table 167. Shionogi Recent Development Table 168. Theratechnologies Inc. Company Information Table 169. Theratechnologies Inc. Business Overview Table 170. Theratechnologies Inc. HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 171. Theratechnologies Inc. HIV Therapy Drug Product Portfolio Table 172. Theratechnologies Inc. Recent Development Table 173. ViiV Healthcare Company Information Table 174. ViiV Healthcare Business Overview Table 175. ViiV Healthcare HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 176. ViiV Healthcare HIV Therapy Drug Product Portfolio Table 177. ViiV Healthcare Recent Development Table 178. GSK Company Information Table 179. GSK Business Overview Table 180. GSK HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 181. GSK HIV Therapy Drug Product Portfolio Table 182. GSK Recent Development Table 183. Pfizer Company Information Table 184. Pfizer Business Overview Table 185. Pfizer HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 186. Pfizer HIV Therapy Drug Product Portfolio Table 187. Pfizer Recent Development Table 188. Johnson & Johnson Company Information Table 189. Johnson & Johnson Business Overview Table 190. Johnson & Johnson HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 191. Johnson & Johnson HIV Therapy Drug Product Portfolio Table 192. Johnson & Johnson Recent Development Table 193. Teva Pharmaceuticals Company Information Table 194. Teva Pharmaceuticals Business Overview Table 195. Teva Pharmaceuticals HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 196. Teva Pharmaceuticals HIV Therapy Drug Product Portfolio Table 197. Teva Pharmaceuticals Recent Development Table 198. Abbott Company Information Table 199. Abbott Business Overview Table 200. Abbott HIV Therapy Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 201. Abbott HIV Therapy Drug Product Portfolio Table 202. Abbott Recent Development Table 203. North America HIV Therapy Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 204. North America HIV Therapy Drug Sales by Country (2021-2026) & (K Units) Table 205. North America HIV Therapy Drug Sales Market Share by Country (2021-2026) Table 206. North America HIV Therapy Drug Sales Forecast by Country (2027-2032) & (K Units) Table 207. North America HIV Therapy Drug Sales Market Share Forecast by Country (2027-2032) Table 208. North America HIV Therapy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 209. North America HIV Therapy Drug Market Size by Country (2021-2026) & (US$ Million) Table 210. North America HIV Therapy Drug Market Share by Country (2021-2026) Table 211. North America HIV Therapy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 212. North America HIV Therapy Drug Market Share Forecast by Country (2027-2032) Table 213. Europe HIV Therapy Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 214. Europe HIV Therapy Drug Sales by Country (2021-2026) & (K Units) Table 215. Europe HIV Therapy Drug Sales Market Share by Country (2021-2026) Table 216. Europe HIV Therapy Drug Sales Forecast by Country (2027-2032) & (K Units) Table 217. Europe HIV Therapy Drug Sales Market Share Forecast by Country (2027-2032) Table 218. Europe HIV Therapy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 219. Europe HIV Therapy Drug Market Size by Country (2021-2026) & (US$ Million) Table 220. Europe HIV Therapy Drug Market Share by Country (2021-2026) Table 221. Europe HIV Therapy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 222. Europe HIV Therapy Drug Market Share Forecast by Country (2027-2032) Table 223. Asia-Pacific HIV Therapy Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 224. Asia-Pacific HIV Therapy Drug Sales by Country (2021-2026) & (K Units) Table 225. Asia-Pacific HIV Therapy Drug Sales Market Share by Country (2021-2026) Table 226. Asia-Pacific HIV Therapy Drug Sales Forecast by Country (2027-2032) & (K Units) Table 227. Asia-Pacific HIV Therapy Drug Sales Market Share Forecast by Country (2027-2032) Table 228. Asia-Pacific HIV Therapy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 229. Asia-Pacific HIV Therapy Drug Market Size by Country (2021-2026) & (US$ Million) Table 230. Asia-Pacific HIV Therapy Drug Market Share by Country (2021-2026) Table 231. Asia-Pacific HIV Therapy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 232. Asia-Pacific HIV Therapy Drug Market Share Forecast by Country (2027-2032) Table 233. Latin America HIV Therapy Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 234. Latin America HIV Therapy Drug Sales by Country (2021-2026) & (K Units) Table 235. Latin America HIV Therapy Drug Sales Market Share by Country (2021-2026) Table 236. Latin America HIV Therapy Drug Sales Forecast by Country (2027-2032) & (K Units) Table 237. Latin America HIV Therapy Drug Sales Market Share Forecast by Country (2027-2032) Table 238. Latin America HIV Therapy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 239. Latin America HIV Therapy Drug Market Size by Country (2021-2026) & (US$ Million) Table 240. Latin America HIV Therapy Drug Market Share by Country (2021-2026) Table 241. Latin America HIV Therapy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 242. Latin America HIV Therapy Drug Market Share Forecast by Country (2027-2032) Table 243. Middle East and Africa HIV Therapy Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 244. Middle East and Africa HIV Therapy Drug Sales by Country (2021-2026) & (K Units) Table 245. Middle East and Africa HIV Therapy Drug Sales Market Share by Country (2021-2026) Table 246. Middle East and Africa HIV Therapy Drug Sales Forecast by Country (2027-2032) & (K Units) Table 247. Middle East and Africa HIV Therapy Drug Sales Market Share Forecast by Country (2027-2032) Table 248. Middle East and Africa HIV Therapy Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 249. Middle East and Africa HIV Therapy Drug Market Size by Country (2021-2026) & (US$ Million) Table 250. Middle East and Africa HIV Therapy Drug Market Share by Country (2021-2026) Table 251. Middle East and Africa HIV Therapy Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 252. Middle East and Africa HIV Therapy Drug Market Share Forecast by Country (2027-2032) Table 253. Key Raw Materials Table 254. Raw Materials Key Suppliers Table 255. HIV Therapy Drug Distributors List Table 256. HIV Therapy Drug Customers List Table 257. Research Programs/Design for This Report Table 258. Authors List of This Report Table 259. Secondary Sources Table 260. Primary Sources List of Figures Figure 1. HIV Therapy Drug Image Figure 2. Global HIV Therapy Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HIV Therapy Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global HIV Therapy Drug Sales (2021-2032) & (K Units) Figure 5. Hiv Integrated Enzyme Chain Transfer Inhibitor Image Figure 6. Global Hiv Integrated Enzyme Chain Transfer Inhibitor Sales YoY Growth (2021-2032) & (K Units) Figure 7. Multi-Type Combined Drugs Image Figure 8. Global Multi-Type Combined Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Non-Nucleoside Reverse Transcription Enzyme Inhibitors Image Figure 10. Global Non-Nucleoside Reverse Transcription Enzyme Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 11. Nucleoside Reverse Transcription Enzyme Inhibitors Image Figure 12. Global Nucleoside Reverse Transcription Enzyme Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global HIV Therapy Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global HIV Therapy Drug Market Share by Type 2025 VS 2032 Figure 15. North America HIV Therapy Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America HIV Therapy Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe HIV Therapy Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe HIV Therapy Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific HIV Therapy Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific HIV Therapy Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America HIV Therapy Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America HIV Therapy Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa HIV Therapy Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa HIV Therapy Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 HIV Therapy Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Pharmacy Image Figure 32. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global HIV Therapy Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global HIV Therapy Drug Market Share by Application 2025 VS 2032 Figure 35. North America HIV Therapy Drug Sales Market Share in Volume by Application in 2025 Figure 36. North America HIV Therapy Drug Sales Market Share in Value by Application in 2025 Figure 37. Europe HIV Therapy Drug Sales Market Share in Volume by Application in 2025 Figure 38. Europe HIV Therapy Drug Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific HIV Therapy Drug Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific HIV Therapy Drug Sales Market Share in Value by Application in 2025 Figure 41. Latin America HIV Therapy Drug Sales Market Share in Volume by Application in 2025 Figure 42. Latin America HIV Therapy Drug Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa HIV Therapy Drug Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa HIV Therapy Drug Sales Market Share in Value by Application in 2025 Figure 45. North America HIV Therapy Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America HIV Therapy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America HIV Therapy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America HIV Therapy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe HIV Therapy Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe HIV Therapy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe HIV Therapy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe HIV Therapy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific HIV Therapy Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific HIV Therapy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific HIV Therapy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific HIV Therapy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America HIV Therapy Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America HIV Therapy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America HIV Therapy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America HIV Therapy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa HIV Therapy Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa HIV Therapy Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa HIV Therapy Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa HIV Therapy Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. HIV Therapy Drug Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. HIV Therapy Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Hiv Integrated Enzyme Chain Transfer Inhibitor
  • Multi-Type Combined Drugs
  • Non-Nucleoside Reverse Transcription Enzyme Inhibitors
  • Nucleoside Reverse Transcription Enzyme Inhibitors
Applications
  • Hospital
  • Clinic
  • Pharmacy
Companies covered
  • AbbVie Inc.
  • Affine Formulations Limited
  • Beacon Pharmaceuticals
  • Biocon Limited
  • Boehringer Ingelheim
  • Bristol-Myers Squibb Company
  • Cipla
  • Frontier Biotechnologies
  • Genentech, Inc.
  • Gilead Sciences, Inc
  • IPCA Laboratories
  • Janssen Pharmaceuticals, Inc.
  • Julphar Bangladesh
  • Merck & Co
  • MSD
  • Mylan Pharmaceuticals Inc.
  • Natco Pharma
  • Roche Holding AG
  • Shionogi
  • Theratechnologies Inc.
  • ViiV Healthcare
  • GSK
  • Pfizer
  • Johnson & Johnson
  • Teva Pharmaceuticals
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global HIV Therapy Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global HIV Therapy Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 HIV Therapy Drug Market by Type
  6. 1.3.1 Hiv Integrated Enzyme Chain Transfer Inhibitor
  7. 1.3.2 Multi-Type Combined Drugs
  8. 1.3.3 Non-Nucleoside Reverse Transcription Enzyme Inhibitors
  9. 1.3.4 Nucleoside Reverse Transcription Enzyme Inhibitors
  10. 1.4 Global HIV Therapy Drug Market Size by Type
  11. 1.4.1 Global HIV Therapy Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global HIV Therapy Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global HIV Therapy Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America HIV Therapy Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe HIV Therapy Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific HIV Therapy Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America HIV Therapy Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa HIV Therapy Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 HIV Therapy Drug Industry Trends
  2. 2.2 HIV Therapy Drug Industry Drivers
  3. 2.3 HIV Therapy Drug Industry Opportunities and Challenges
  4. 2.4 HIV Therapy Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by HIV Therapy Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by HIV Therapy Drug Sales (2021-2026)
  3. 3.3 Global Top Players by HIV Therapy Drug Price (2021-2026)
  4. 3.4 Global HIV Therapy Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global HIV Therapy Drug Major Company Production Sites & Headquarters
  6. 3.6 Global HIV Therapy Drug Company, Product Type & Application
  7. 3.7 Global HIV Therapy Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global HIV Therapy Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 HIV Therapy Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 HIV Therapy Drug Tier 1, Tier 2, and Tier 3
4 HIV Therapy Drug Regional Status and Outlook
  1. 4.1 Global HIV Therapy Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global HIV Therapy Drug Historic Market Size by Region
  3. 4.2.1 Global HIV Therapy Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global HIV Therapy Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global HIV Therapy Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global HIV Therapy Drug Forecasted Market Size by Region
  7. 4.3.1 Global HIV Therapy Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global HIV Therapy Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global HIV Therapy Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 HIV Therapy Drug by Application
  1. 5.1 HIV Therapy Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Pharmacy
  5. 5.2 Global HIV Therapy Drug Market Size by Application
  6. 5.2.1 Global HIV Therapy Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global HIV Therapy Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global HIV Therapy Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America HIV Therapy Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe HIV Therapy Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific HIV Therapy Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America HIV Therapy Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa HIV Therapy Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AbbVie Inc.
  2. 6.1.1 AbbVie Inc. Company Information
  3. 6.1.2 AbbVie Inc. Business Overview
  4. 6.1.3 AbbVie Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AbbVie Inc. HIV Therapy Drug Product Portfolio
  6. 6.1.5 AbbVie Inc. Recent Developments
  7. 6.2 Affine Formulations Limited
  8. 6.2.1 Affine Formulations Limited Company Information
  9. 6.2.2 Affine Formulations Limited Business Overview
  10. 6.2.3 Affine Formulations Limited HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Affine Formulations Limited HIV Therapy Drug Product Portfolio
  12. 6.2.5 Affine Formulations Limited Recent Developments
  13. 6.3 Beacon Pharmaceuticals
  14. 6.3.1 Beacon Pharmaceuticals Company Information
  15. 6.3.2 Beacon Pharmaceuticals Business Overview
  16. 6.3.3 Beacon Pharmaceuticals HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Beacon Pharmaceuticals HIV Therapy Drug Product Portfolio
  18. 6.3.5 Beacon Pharmaceuticals Recent Developments
  19. 6.4 Biocon Limited
  20. 6.4.1 Biocon Limited Company Information
  21. 6.4.2 Biocon Limited Business Overview
  22. 6.4.3 Biocon Limited HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Biocon Limited HIV Therapy Drug Product Portfolio
  24. 6.4.5 Biocon Limited Recent Developments
  25. 6.5 Boehringer Ingelheim
  26. 6.5.1 Boehringer Ingelheim Company Information
  27. 6.5.2 Boehringer Ingelheim Business Overview
  28. 6.5.3 Boehringer Ingelheim HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Boehringer Ingelheim HIV Therapy Drug Product Portfolio
  30. 6.5.5 Boehringer Ingelheim Recent Developments
  31. 6.6 Bristol-Myers Squibb Company
  32. 6.6.1 Bristol-Myers Squibb Company Company Information
  33. 6.6.2 Bristol-Myers Squibb Company Business Overview
  34. 6.6.3 Bristol-Myers Squibb Company HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bristol-Myers Squibb Company HIV Therapy Drug Product Portfolio
  36. 6.6.5 Bristol-Myers Squibb Company Recent Developments
  37. 6.7 Cipla
  38. 6.7.1 Cipla Company Information
  39. 6.7.2 Cipla Business Overview
  40. 6.7.3 Cipla HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Cipla HIV Therapy Drug Product Portfolio
  42. 6.7.5 Cipla Recent Developments
  43. 6.8 Frontier Biotechnologies
  44. 6.8.1 Frontier Biotechnologies Company Information
  45. 6.8.2 Frontier Biotechnologies Business Overview
  46. 6.8.3 Frontier Biotechnologies HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Frontier Biotechnologies HIV Therapy Drug Product Portfolio
  48. 6.8.5 Frontier Biotechnologies Recent Developments
  49. 6.9 Genentech, Inc.
  50. 6.9.1 Genentech, Inc. Company Information
  51. 6.9.2 Genentech, Inc. Business Overview
  52. 6.9.3 Genentech, Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Genentech, Inc. HIV Therapy Drug Product Portfolio
  54. 6.9.5 Genentech, Inc. Recent Developments
  55. 6.10 Gilead Sciences, Inc
  56. 6.10.1 Gilead Sciences, Inc Company Information
  57. 6.10.2 Gilead Sciences, Inc Business Overview
  58. 6.10.3 Gilead Sciences, Inc HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Gilead Sciences, Inc HIV Therapy Drug Product Portfolio
  60. 6.10.5 Gilead Sciences, Inc Recent Developments
  61. 6.11 IPCA Laboratories
  62. 6.11.1 IPCA Laboratories Company Information
  63. 6.11.2 IPCA Laboratories Business Overview
  64. 6.11.3 IPCA Laboratories HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 IPCA Laboratories HIV Therapy Drug Product Portfolio
  66. 6.11.5 IPCA Laboratories Recent Developments
  67. 6.12 Janssen Pharmaceuticals, Inc.
  68. 6.12.1 Janssen Pharmaceuticals, Inc. Company Information
  69. 6.12.2 Janssen Pharmaceuticals, Inc. Business Overview
  70. 6.12.3 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Janssen Pharmaceuticals, Inc. HIV Therapy Drug Product Portfolio
  72. 6.12.5 Janssen Pharmaceuticals, Inc. Recent Developments
  73. 6.13 Julphar Bangladesh
  74. 6.13.1 Julphar Bangladesh Company Information
  75. 6.13.2 Julphar Bangladesh Business Overview
  76. 6.13.3 Julphar Bangladesh HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Julphar Bangladesh HIV Therapy Drug Product Portfolio
  78. 6.13.5 Julphar Bangladesh Recent Developments
  79. 6.14 Merck & Co
  80. 6.14.1 Merck & Co Company Information
  81. 6.14.2 Merck & Co Business Overview
  82. 6.14.3 Merck & Co HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Merck & Co HIV Therapy Drug Product Portfolio
  84. 6.14.5 Merck & Co Recent Developments
  85. 6.15 MSD
  86. 6.15.1 MSD Company Information
  87. 6.15.2 MSD Business Overview
  88. 6.15.3 MSD HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 MSD HIV Therapy Drug Product Portfolio
  90. 6.15.5 MSD Recent Developments
  91. 6.16 Mylan Pharmaceuticals Inc.
  92. 6.16.1 Mylan Pharmaceuticals Inc. Company Information
  93. 6.16.2 Mylan Pharmaceuticals Inc. Business Overview
  94. 6.16.3 Mylan Pharmaceuticals Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Mylan Pharmaceuticals Inc. HIV Therapy Drug Product Portfolio
  96. 6.16.5 Mylan Pharmaceuticals Inc. Recent Developments
  97. 6.17 Natco Pharma
  98. 6.17.1 Natco Pharma Company Information
  99. 6.17.2 Natco Pharma Business Overview
  100. 6.17.3 Natco Pharma HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Natco Pharma HIV Therapy Drug Product Portfolio
  102. 6.17.5 Natco Pharma Recent Developments
  103. 6.18 Roche Holding AG
  104. 6.18.1 Roche Holding AG Company Information
  105. 6.18.2 Roche Holding AG Business Overview
  106. 6.18.3 Roche Holding AG HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Roche Holding AG HIV Therapy Drug Product Portfolio
  108. 6.18.5 Roche Holding AG Recent Developments
  109. 6.19 Shionogi
  110. 6.19.1 Shionogi Company Information
  111. 6.19.2 Shionogi Business Overview
  112. 6.19.3 Shionogi HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Shionogi HIV Therapy Drug Product Portfolio
  114. 6.19.5 Shionogi Recent Developments
  115. 6.20 Theratechnologies Inc.
  116. 6.20.1 Theratechnologies Inc. Company Information
  117. 6.20.2 Theratechnologies Inc. Business Overview
  118. 6.20.3 Theratechnologies Inc. HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Theratechnologies Inc. HIV Therapy Drug Product Portfolio
  120. 6.20.5 Theratechnologies Inc. Recent Developments
  121. 6.21 ViiV Healthcare
  122. 6.21.1 ViiV Healthcare Company Information
  123. 6.21.2 ViiV Healthcare Business Overview
  124. 6.21.3 ViiV Healthcare HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 ViiV Healthcare HIV Therapy Drug Product Portfolio
  126. 6.21.5 ViiV Healthcare Recent Developments
  127. 6.22 GSK
  128. 6.22.1 GSK Company Information
  129. 6.22.2 GSK Business Overview
  130. 6.22.3 GSK HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 GSK HIV Therapy Drug Product Portfolio
  132. 6.22.5 GSK Recent Developments
  133. 6.23 Pfizer
  134. 6.23.1 Pfizer Company Information
  135. 6.23.2 Pfizer Business Overview
  136. 6.23.3 Pfizer HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Pfizer HIV Therapy Drug Product Portfolio
  138. 6.23.5 Pfizer Recent Developments
  139. 6.24 Johnson & Johnson
  140. 6.24.1 Johnson & Johnson Company Information
  141. 6.24.2 Johnson & Johnson Business Overview
  142. 6.24.3 Johnson & Johnson HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Johnson & Johnson HIV Therapy Drug Product Portfolio
  144. 6.24.5 Johnson & Johnson Recent Developments
  145. 6.25 Teva Pharmaceuticals
  146. 6.25.1 Teva Pharmaceuticals Company Information
  147. 6.25.2 Teva Pharmaceuticals Business Overview
  148. 6.25.3 Teva Pharmaceuticals HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Teva Pharmaceuticals HIV Therapy Drug Product Portfolio
  150. 6.25.5 Teva Pharmaceuticals Recent Developments
  151. 6.26 Abbott
  152. 6.26.1 Abbott Company Information
  153. 6.26.2 Abbott Business Overview
  154. 6.26.3 Abbott HIV Therapy Drug Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Abbott HIV Therapy Drug Product Portfolio
  156. 6.26.5 Abbott Recent Developments
7 North America by Country
  1. 7.1 North America HIV Therapy Drug Sales by Country
  2. 7.1.1 North America HIV Therapy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America HIV Therapy Drug Sales by Country (2021-2026)
  4. 7.1.3 North America HIV Therapy Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America HIV Therapy Drug Market Size by Country
  6. 7.2.1 North America HIV Therapy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America HIV Therapy Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America HIV Therapy Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe HIV Therapy Drug Sales by Country
  2. 8.1.1 Europe HIV Therapy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe HIV Therapy Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe HIV Therapy Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe HIV Therapy Drug Market Size by Country
  6. 8.2.1 Europe HIV Therapy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe HIV Therapy Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe HIV Therapy Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific HIV Therapy Drug Sales by Country
  2. 9.1.1 Asia-Pacific HIV Therapy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific HIV Therapy Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific HIV Therapy Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific HIV Therapy Drug Market Size by Country
  6. 9.2.1 Asia-Pacific HIV Therapy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific HIV Therapy Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific HIV Therapy Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America HIV Therapy Drug Sales by Country
  2. 10.1.1 South America HIV Therapy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America HIV Therapy Drug Sales by Country (2021-2026)
  4. 10.1.3 South America HIV Therapy Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America HIV Therapy Drug Market Size by Country
  6. 10.2.1 South America HIV Therapy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America HIV Therapy Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America HIV Therapy Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa HIV Therapy Drug Sales by Country
  2. 11.1.1 Middle East and Africa HIV Therapy Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa HIV Therapy Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa HIV Therapy Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa HIV Therapy Drug Market Size by Country
  6. 11.2.1 Middle East and Africa HIV Therapy Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa HIV Therapy Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa HIV Therapy Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 HIV Therapy Drug Value Chain Analysis
  2. 12.1.1 HIV Therapy Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 HIV Therapy Drug Production Mode & Process
  7. 12.2 HIV Therapy Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 HIV Therapy Drug Distributors
  10. 12.2.3 HIV Therapy Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst